Rheumatologic serologies - Revision history

Aidan at 17:12, 19 September 2024

2024-09-19T17:12:37Z

← Older revision		Revision as of 17:12, 19 September 2024
Line 73:		Line 73:
	\|}		\|}

	[[Category:~~Investigation~~]]		[[Category:Investigations]]
	[[Category:Rheumatology]]		[[Category:Rheumatology]]

Aidan at 15:19, 17 July 2021

2021-07-17T15:19:30Z

← Older revision		Revision as of 15:19, 17 July 2021
Line 69:		Line 69:
	\|-		\|-
	\|Anti-parietal cell antibodies		\|Anti-parietal cell antibodies
	\|[[Autoimmune gastritis]] and [[pernicious anemia]]; also [[Addison disease]], [[autoimmune thyroiditis]], [[type 1 diabetes mellitus]]		\|[[Autoimmune gastritis]] and [[pernicious anemia]]; also [[Addison disease]], [[autoimmune thyroiditis]], [[type 1 diabetes mellitus]], and [[primary ovarian failure]]
	\|		\|
	\|}		\|}

Aidan at 15:19, 17 July 2021

2021-07-17T15:19:10Z

← Older revision		Revision as of 15:19, 17 July 2021
Line 69:		Line 69:
	\|-		\|-
	\|Anti-parietal cell antibodies		\|Anti-parietal cell antibodies
	\|[[Autoimmune gastritis]], [[pernicious anemia]]		\|[[Autoimmune gastritis]] and [[pernicious anemia]]; also [[Addison disease]], [[autoimmune thyroiditis]], [[type 1 diabetes mellitus]]
	\|		\|
	\|}		\|}

Aidan at 15:18, 17 July 2021

2021-07-17T15:18:17Z

← Older revision		Revision as of 15:18, 17 July 2021
Line 28:		Line 28:
	\|		\|
	\|-		\|-
	\|Anti-Ro/~~SSA~~		\|Anti-Ro/SS-A
	\|[[Sjögren syndrome]]~~<br~~ ~~/>Neonatal~~ heart block~~<br~~ />[[Systemic lupus erythematosus\|~~Subacute~~ SLE]]		\|[[Sjögren syndrome]], neonatal heart block, [[Systemic lupus erythematosus\|subacute SLE]]
			\|
			\|-
			\|Anti-Ro/SS-A 60 kDa
			\|
			\|
			\|-
			\|Anti-Ro/SS-A 52 kDa
			\|[[Systemic sclerosis]] and [[SLE]], often with other antibodies present[[CiteRef::hervier2009cl]]
	\|		\|
	\|-		\|-
	\|Anti-La/SSB		\|Anti-La/SSB
	\|[[Sjögren syndrome]]~~<br~~ ~~/>Sicca~~ syndrome~~<br~~ />[[Neonatal lupus\|~~Neonatal~~ SLE]]		\|[[Sjögren syndrome]], sicca syndrome, [[Neonatal lupus\|neonatal SLE]]
	\|		\|
	\|-		\|-
Line 41:		Line 49:
	\|-		\|-
	\|Anti-Jo-1		\|Anti-Jo-1
	\|[[Polymyositis]]~~<br~~ />[[~~Antisynthetase~~ syndrome]]		\|[[Polymyositis]], [[antisynthetase syndrome]]
	\|		\|
	\|-		\|-
Line 58:		Line 66:
	\|Anti-MPO (pANCA)		\|Anti-MPO (pANCA)
	\|[[Microscopic polyangiitis\|MPA]] and [[Eosinophilic granulomatosis with polyangiitis\|eGPA]]		\|[[Microscopic polyangiitis\|MPA]] and [[Eosinophilic granulomatosis with polyangiitis\|eGPA]]
			\|
			\|-
			\|Anti-parietal cell antibodies
			\|[[Autoimmune gastritis]], [[pernicious anemia]]
	\|		\|
	\|}		\|}

Aidan at 19:24, 19 August 2020

2020-08-19T19:24:21Z

← Older revision		Revision as of 19:24, 19 August 2020
Line 1:		Line 1:
			{\| class="wikitable"
	{\|
	! Test		!Test
	! Association		!Association
	! Correlates with dz activity?		!Correlates with dz activity?
	\|-		\|-
	\| ANA		\|ANA
	\| [[SLE]]		\|[[SLE]]
	\| No		\|No
	\|-		\|-
	\| ANA (centromere pattern)		\|ANA (centromere pattern)
	\| CREST syndrome, SSc, PH		\|[[CREST syndrome]], [[Systemic sclerosis\|SSc]], PH
	\|		\|
	\|-		\|-
	\| Anti-Smith		\|Anti-Smith
	\| [[SLE]] (most specific)		\|[[SLE]] (most specific)
	\| No		\|No
	\|-		\|-
	\| Anti-dsDNA		\|Anti-dsDNA
	\| [[SLE]]		\|[[SLE]]
	\| Yes, especially renal disease		\|Yes, especially renal disease
	\|-		\|-
	\| Anti-histone		\|Anti-histone
	\| [[Drug-induced lupus]]		\|[[Drug-induced lupus]]
	\|		\|
	\|-		\|-
	\| Anti-U1-RNP		\|Anti-U1-RNP
	\| Mixed CTD		\|[[Mixed connective tissue disease\|Mixed CTD]]
	\|		\|
	\|-		\|-
	\| Anti-Ro/SSA		\|Anti-Ro/SSA
	\| [[Sjögren syndrome]]<br/>Neonatal heart block<br/>Subacute SLE		\|[[Sjögren syndrome]]<br />Neonatal heart block<br />[[Systemic lupus erythematosus\|Subacute SLE]]
	\|		\|
	\|-		\|-
	\| Anti-La/SSB		\|Anti-La/SSB
	\| [[Sjögren syndrome]]<br/>Sicca syndrome<br/>Neonatal SLE		\|[[Sjögren syndrome]]<br />Sicca syndrome<br />[[Neonatal lupus\|Neonatal SLE]]
	\|		\|
	\|-		\|-
	\| Anti-Scl-70		\|Anti-Scl-70
	\| SSc and pulmonary fibrosis, dcSSc		\|[[Systemic sclerosis\|SSc and pulmonary fibrosis]], [[Systemic sclerosis\|dcSSc]]
	\|		\|
	\|-		\|-
	\| Anti-Jo-1		\|Anti-Jo-1
	\| Polymyositis<br/>Antisynthetase syndrome		\|[[Polymyositis]]<br />[[Antisynthetase syndrome]]
	\|		\|
	\|-		\|-
	\| Anti-CCP		\|Anti-CCP
	\| RA (most specific)		\|[[Rheumatoid arthritis\|RA]] (most specific)
	\|		\|
	\|-		\|-
	\| Anti-smooth muscle		\|Anti-smooth muscle
	\| Autoimmune hepatitis		\|[[Autoimmune hepatitis]]
	\|		\|
	\|-		\|-
	\| Anti-PR3 (cANCA)		\|Anti-PR3 (cANCA)
			\|[[Granulomatosis with polyangiitis\|GPA]]
	\| GPA
	\|		\|
	\|-		\|-
	\| Anti-MPO (pANCA)		\|Anti-MPO (pANCA)
			\|[[Microscopic polyangiitis\|MPA]] and [[Eosinophilic granulomatosis with polyangiitis\|eGPA]]
	\| MPA and eGPA
	\|		\|
	\|}		\|}

Maintenance script: Imported from text file

2020-07-04T01:17:54Z

Imported from text file

New page

{|
! Test
! Association
! Correlates with dz activity?
|-
| ANA
| [[SLE]]
| No
|-
| ANA (centromere pattern)
| CREST syndrome, SSc, PH
|
|-
| Anti-Smith
| [[SLE]] (most specific)
| No
|-
| Anti-dsDNA
| [[SLE]]
| Yes, especially renal disease
|-
| Anti-histone
| [[Drug-induced lupus]]
|
|-
| Anti-U1-RNP
| Mixed CTD
|
|-
| Anti-Ro/SSA
| [[Sjögren syndrome]] Neonatal heart block Subacute SLE
|
|-
| Anti-La/SSB
| [[Sjögren syndrome]] Sicca syndrome Neonatal SLE
|
|-
| Anti-Scl-70
| SSc and pulmonary fibrosis, dcSSc
|
|-
| Anti-Jo-1
| Polymyositis Antisynthetase syndrome
|
|-
| Anti-CCP
| RA (most specific)
|
|-
| Anti-smooth muscle
| Autoimmune hepatitis
|
|-
| Anti-PR3 (cANCA)
| GPA
|
|-
| Anti-MPO (pANCA)
| MPA and eGPA
|
|}

[[Category:Investigation]]
[[Category:Rheumatology]]